Sofinnova Investments, based in California, backs life sciences companies at Series A and Series B, can lead rounds with $10M to $30M checks, and has notable investments like Natera and Seattle Genetics.
10 people on the investing team, 7 of them partners who can make the call. Partners are listed first.










Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Sofinnova Investments reports entry at series a, series b.
Sofinnova Investments reports checks of $10M to $30M.
Yes. Sofinnova Investments says it can lead.
Jim Healy (Managing Partner), Maha Katabi (General Partner), Chris Carpenter (Executive Partner, Private Equity), Jakob Dupont (Executive Partner, Private Equity), Jonathan Leff (Executive Partner, Private Equity), Lars Ekman (Executive Partner, Private Equity).
No recent activity since September 2026.
Work at Sofinnova Investments? Claim or correct this profile.